Zevra Therapeutics (ZVRA) Depreciation & Amortization (CF) (2014 - 2026)
Zevra Therapeutics (ZVRA) recorded Depreciation & Amortization (CF) of $378,000 in Q3 2026, down 3.6% from $392,000 a year earlier but up 3.8% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends
On a TTM basis, Zevra Therapeutics' Depreciation & Amortization (CF) came in at $1.47 million as of Sep 30, 2026, down 72.4% year-over-year; for FY2025, it came in at $4.05 million, down 36.5% from FY2024.
- Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of 71.5% (FY2020 to FY2025).
- Across earlier years, Depreciation & Amortization (CF) came in at $6.39 million in FY2024 (+535.1%), $1.01 million in FY2023 (+6.6%), $944,000 in FY2022 (+267.3%) and $257,000 in FY2021 (-5.9%).
- Quarterly Depreciation & Amortization (CF) has ranged from $62,000 in Q3 2023 to $1.65 million in Q2 2025 over the past five years.
- On a year-over-year basis, Depreciation & Amortization (CF) has declined for five consecutive quarters, with an average decline of 24.0% over the last eight quarters.
- Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 512.3% in Q3 2022, against a decline of 84.4% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $364,000 (Q2 2026), $368,000 (Q1 2026) and $362,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 378,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 378,000.00 |
| Jun 30, 2026 | 364,000.00 |
| Mar 31, 2026 | 368,000.00 |
| Dec 31, 2025 | 362,000.00 |
| Sep 30, 2025 | 392,000.00 |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.56 Mn |
| Dec 31, 2023 | 787,000.00 |
| Sep 30, 2023 | 62,000.00 |
| Jun 30, 2023 | 78,000.00 |
| Mar 31, 2023 | 79,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 398,000.00 |
| Jun 30, 2022 | 181,000.00 |
| Mar 31, 2022 | 65,000.00 |
| Dec 31, 2021 | 64,000.00 |
API Access
Zevra Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();